K2M Shares Fall 3% Midday Amid Report Biedermann Technologies Filed Suit Against Co. Claiming K2M Knew Or Was Willfully Blind To Biedermann's Patents For Devices Used To Treat Complex, Degenerative Spine Disorders
Benzinga Newsdesk